$866 Million is the total value of Redmile Group, LLC's 54 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 79.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ISHARES TRput | $49,208,000 | – | 450,000 | +100.0% | 5.68% | – | |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $43,633,000 | +51.9% | 332,567 | +46.0% | 5.04% | +44.6% |
| B108PS | Sell | ACTAVIS PLC | $39,545,000 | +0.3% | 163,898 | -7.2% | 4.57% | -4.4% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $35,583,000 | +18.7% | 784,459 | +8.4% | 4.11% | +13.1% |
| CELG | New | CELGENE CORP | $35,012,000 | – | 369,400 | +100.0% | 4.04% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $33,956,000 | +32.9% | 5,706,906 | -25.4% | 3.92% | +26.6% |
| MCK | New | MCKESSON CORP | $31,491,000 | – | 161,765 | +100.0% | 3.64% | – |
| CMRX | Sell | CHIMERIX INC | $30,963,000 | +5.5% | 1,121,032 | -16.2% | 3.58% | +0.5% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $29,781,000 | -19.2% | 8,342,045 | +3.2% | 3.44% | -23.1% |
| RCPT | Sell | RECEPTOS INC | $27,321,000 | -14.9% | 439,878 | -41.6% | 3.16% | -19.0% |
| TRIV | Buy | TRIVASCULAR TECHNOLOGIES INC | $25,534,000 | +15.3% | 1,751,518 | +13.7% | 2.95% | +9.8% |
| RAD | Buy | RITE AID CORP | $25,462,000 | +43.5% | 5,260,710 | +112.7% | 2.94% | +36.7% |
| HCA | Sell | HCA HOLDINGS INC | $23,151,000 | -33.2% | 328,292 | -46.6% | 2.67% | -36.4% |
| CSLT | Buy | CASTLIGHT HEALTH INC | $21,789,000 | +32.4% | 1,683,817 | +44.6% | 2.52% | +26.0% |
| AAVL | New | AVALANCHE BIOTECHNOLOGIES IN | $21,531,000 | – | 699,460 | +100.0% | 2.49% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $20,860,000 | – | 231,389 | +100.0% | 2.41% | – |
| GMED | Buy | GLOBUS MED INCcl a | $19,007,000 | -4.6% | 966,300 | +16.0% | 2.20% | -9.2% |
| CBST | New | CUBIST PHARMACEUTICALS INC | $18,824,000 | – | 283,756 | +100.0% | 2.17% | – |
| ZSPH | New | ZS PHARMA INC | $18,600,000 | – | 474,132 | +100.0% | 2.15% | – |
| NUVA | Sell | NUVASIVE INC | $17,381,000 | -2.7% | 498,441 | -0.8% | 2.01% | -7.3% |
| HWAY | Sell | HEALTHWAYS INC | $16,445,000 | -24.1% | 1,026,503 | -16.9% | 1.90% | -27.7% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $16,284,000 | +0.7% | 1,066,415 | +11.0% | 1.88% | -4.1% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $15,903,000 | -6.2% | 1,453,655 | +28.2% | 1.84% | -10.7% |
| HNT | New | HEALTH NET INC | $15,444,000 | – | 334,935 | +100.0% | 1.78% | – |
| MODN | Buy | MODEL N INC | $14,369,000 | -4.4% | 1,457,278 | +7.1% | 1.66% | -9.0% |
| INSM | New | INSMED INC | $14,233,000 | – | 1,090,624 | +100.0% | 1.64% | – |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $13,758,000 | -16.7% | 1,003,496 | +2.5% | 1.59% | -20.7% |
| FLDM | Buy | FLUIDIGM CORP DEL | $13,711,000 | +18.8% | 559,622 | +42.6% | 1.58% | +13.1% |
| WCG | New | WELLCARE HEALTH PLANS INC | $13,578,000 | – | 225,033 | +100.0% | 1.57% | – |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $12,936,000 | -63.5% | 123,792 | -66.5% | 1.49% | -65.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $12,778,000 | -56.1% | 177,079 | -62.2% | 1.48% | -58.2% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $12,173,000 | – | 51,025 | +100.0% | 1.41% | – |
| PRQR | New | PROQR THRAPEUTICS N V | $12,067,000 | – | 765,232 | +100.0% | 1.39% | – |
| ARAY | Sell | ACCURAY INC | $12,002,000 | -26.9% | 1,653,128 | -11.4% | 1.39% | -30.4% |
| CIVI | New | CIVITAS SOLUTIONS INC | $9,672,000 | – | 619,236 | +100.0% | 1.12% | – |
| KYTH | Sell | KYTHERA BIOPHARMACEUTICALS I | $9,221,000 | -57.1% | 281,479 | -49.8% | 1.06% | -59.2% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $8,929,000 | -9.2% | 172,772 | -1.5% | 1.03% | -13.5% |
| CYBX | New | CYBERONICS INC | $8,846,000 | – | 172,900 | +100.0% | 1.02% | – |
| CSII | Sell | CARDIOVASCULAR SYS INC DEL | $8,748,000 | -43.1% | 370,208 | -25.0% | 1.01% | -45.8% |
| FLXN | Sell | FLEXION THERAPEUTICS INC | $8,508,000 | +25.2% | 465,933 | -7.6% | 0.98% | +19.3% |
| LOXO | New | LOXO ONCOLOGY INC | $7,094,000 | – | 540,300 | +100.0% | 0.82% | – |
| AKAOQ | Buy | ACHAOGEN INC | $6,903,000 | -23.8% | 770,422 | +18.7% | 0.80% | -27.5% |
| TKAI | New | TOKAI PHARMACEUTICALS INC | $6,273,000 | – | 414,330 | +100.0% | 0.72% | – |
| HMSY | Sell | HMS HLDGS CORP | $5,722,000 | -50.4% | 303,571 | -46.3% | 0.66% | -52.8% |
| SGEN | New | SEATTLE GENETICS INC | $4,768,000 | – | 128,230 | +100.0% | 0.55% | – |
| New | CLOVIS ONCOLOGY INCcall | $4,536,000 | – | 100,000 | +100.0% | 0.52% | – | |
| EHTH | New | EHEALTH INC | $4,290,000 | – | 177,788 | +100.0% | 0.50% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,018,000 | – | 49,200 | +100.0% | 0.35% | – |
| PRTA | Sell | PROTHENA CORP PLC | $2,792,000 | -66.6% | 125,973 | -66.0% | 0.32% | -68.2% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $524,000 | +108.8% | 2,212 | +108.3% | 0.06% | +103.3% |
| IBB | Buy | ISHARES TRnasdq biotec etf | $452,000 | +46.8% | 1,652 | +37.7% | 0.05% | +40.5% |
| OTIC | New | OTONOMY INC | $442,000 | – | 18,400 | +100.0% | 0.05% | – |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $413,000 | +2.5% | 6,500 | 0.0% | 0.05% | -2.0% | |
| IHF | New | ISHARESus hlthcr pr etf | $289,000 | – | 2,700 | +100.0% | 0.03% | – |
| OXBT | Exit | OXYGEN BIOTHERAPEUTICS INC | $0 | – | -12,500 | -100.0% | -0.01% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.01% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -10,000 | -100.0% | -0.02% | – |
| IBB | Exit | ISHARESput | $0 | – | -8,000 | -100.0% | -0.25% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -577,653 | -100.0% | -0.64% | – |
| GERN | Exit | GERON CORP | $0 | – | -2,051,312 | -100.0% | -0.80% | – |
| DSCI | Exit | DERMA SCIENCES INC | $0 | – | -600,677 | -100.0% | -0.84% | – |
| INGN | Exit | INOGEN INC | $0 | – | -450,500 | -100.0% | -1.23% | – |
| OFIX | Exit | ORTHOFIX INTL N V | $0 | – | -280,642 | -100.0% | -1.23% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -213,918 | -100.0% | -2.19% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -163,254 | -100.0% | -2.34% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -222,926 | -100.0% | -2.39% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -346,880 | -100.0% | -2.42% | – |
| ZBH | Exit | ZIMMER HLDGS INC | $0 | – | -256,053 | -100.0% | -3.22% | – |
| AGN | Exit | ALLERGAN INC | $0 | – | -170,400 | -100.0% | -3.50% | – |
| MDT | Exit | MEDTRONIC INC | $0 | – | -589,974 | -100.0% | -4.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.